Stabilization of liposomal functional anchors by cross-linkable lipids by Smith, Cartney
 
STABILIZATION OF LIPOSOMAL FUNCTIONAL ANCHORS 
BY CROSS-LINKABLE LIPIDS 
BY 
 
CARTNEY EATON SMITH 
THESIS 
 
Submitted in partial fulfillment of the requirements 
for the degree of Master of Science in Chemical Engineering 
in the Graduate College of the 









 Micro- and nanoparticles are designed to deliver drugs and contrast agents to their 
target site in a controlled manner. One of the greatest obstacles in the performance of 
such delivery vehicles is their stability in the presence of serum. Here we investigate a 
method to stabilize a class of liposomes in which lipid vesicles are modified post-
fabrication through surface adsorption and anchoring. We hypothesized that the 
sequential adsorption of functional units followed by covalent cross-linking of the 
liposome would provide enhanced stability in the presence of human serum. To 
investigate this hypothesis, liposomes composed of diyne-containing lipids were 
assembled and functionalized via chitosan conjugated with a hydrophobic anchor and the 
magnetic resonance (MR) contrast agent, gadolinium, as a model functionality. This 
strategy served to stabilize the thermodynamically favorable association between 
liposome and modified functional chitosan. Furthermore, the chitosan-coated, cross-
linked liposomes proved more effective as delivery vehicles of MR contrast agents than 
uncross-linked liposomes due to the reduced liposome degradation and chitosan 
desorption. Overall, this study demonstrates a useful method to stabilize a broad class of 
particles used for systemic delivery of various molecular cargos. 
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1.1 Background and Motivation 
The use of micro- and nanoparticles has dramatically improved the efficacy of 
diagnostic and therapeutic agents for various biomedical applications. Encapsulation of 
hydrophobic drugs, for example, allows for the delivery of pharmaceuticals that would 
otherwise be insoluble.1 Furthermore, by altering the size, shape, and surface charge, the 
biodistribution and cellular uptake pathways of the nanoparticle can be tailored for its 
particular application.2-4 In addition, the particle may be conjugated with ligands to 
enhance retention5 or deliver the encapsulated agent to a target site of interest.6, 7 Taken 
together, these attributes have allowed for lower drug dosing, reduced toxicity, and 
enhanced efficacy of therapies, as well as the capability of sensitive diagnostics to probe 
in vivo microenvironments. 
 One of the main challenges in translating nanoparticle formulations from 
benchtop to clinic is in vivo stability. While biomedical nanomaterials may demonstrate 
the desired functionality in a controlled setting, the expected performance may not be 
realized in the dynamic environment of the circulatory system due to premature 
degradation and disassembly of the nanoparticle. One reason for such incidence is related 
to the thermodynamic stability of the particle upon dilution. Below the critical micelle 
concentration (CMC) of a self-assembled structure, the material will dissociate, in which 
case delivery becomes an issue of kinetics of disassembly versus transport to the target 
site.8 Secondly, another factor that determines stability in the presence of serum is protein 
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adsorption. The non-specific binding of serum proteins to the nanoparticle surface causes 
opsonization, and affects biodistribution and cellular uptake.9, 10 Though this can be 
reduced with attachment of poly(ethylene glycol) (PEG) to the surface, there is still a 
need to develop more effective methods to minimize serum-inducing destabilization. 
Thirdly, serum presents a harsh environment due to degradative enzymes that can 
actively digest certain biomaterials that make up nanoparticle formulations, as well as 
charged proteins that can disrupt electrostatic interactions. The kinetics of such processes 
are often activated or enhanced at the elevated temperature of 37 °C. For these reasons, it 
is important to improve nanoparticle stability under physiologically relevant conditions.11 
 We recently developed a strategy of modular surface assembly in which a 
functional unit could be non-covalently attached to a liposome surface post-fabrication 
through electrostatic and hydrophobic interactions between the liposome and a chitosan 
anchor. Due to the factors described above, liposomes are inherently unstable in vivo and, 
depending on composition, can be cleared within hours.12 Therefore, to stabilize the 
chitosan anchor, it is strategic to not only stabilize its association with lipids, but to also 
stabilize the liposome itself. Additionally, it is beneficial to cross-link the liposome rather 
than to perform chemical conjugation to the particle surface due to the inefficiency of 
surface reactions and subsequent purification steps needed, which can be costly and 
damaging to the liposome.13 
 
1.2 Research Plan 
 In this study we examined liposomes composed of cross-linkable lipids and their 
effect on the stability of the chitosan anchor in the presence of serum-supplemented 
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media. The sequential anchoring of the modified chitosan followed by cross-linking of 
diyne lipids via UV irradiation was found to be critical in achieving stability 
enhancement, as supported by thermodynamic analysis. The importance of such 
stabilization was demonstrated through the use of the model chitosan anchor in this study, 
which contained the gadolinium chelate, diethylenetriaminepentaacetic acid (DTPA). The 
sequential adsorption and cross-linking steps provided enhanced magnetic resonance 
(MR) signal contrast after one hour in serum-supplemented media compared to liposomes 
that were cross-linked prior to chitosan adsorption. The results of this study will be of 
great benefit in stabilizing liposomes modified with a wide variety of functional moieties 




MATERIALS AND METHODS 
 
2.1 Synthesis and Characterization of DTPA-Chitosan-g-C18 
 Briefly, chitosan (Sigma-Aldrich) was dissolved at pH 4.7 and reacted with 
stearic acid (Sigma-Aldrich) to create the hydrophobic anchor. The amide formation was 
mediated by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Sigma-Aldrich). 
The resultant chitosan-g-C18 was then precipitated in sodium hydroxide and re-dissolved 
with hydrochloric acid twice. Afterwards, DTPA (Sigma-Aldrich) was dissolved with 
Tetramethylethylenediamine (TEMED, Sigma-Aldrich) and reacted with chitosan-g-C18 
by EDC-mediated amide formation once again. The product was purified by dialysis 
(MWCO 6,000-8,000, Fisher Scientific), lyophilized, and stored as a powder. 
 The degree of substitution of the alkyl chain was quantified by 2,4,6- 
trinitrobenzene sulfonic acid (TNBS, Sigma-Aldrich), which was used as a colorimetric 
assay for primary amines to determine the number of remaining, unconjugated 
glucosamine units. The degree of substitution of DTPA was measured by titration of 
DTPA-chitosan-g-C18 with gadolinium (GdCl3!6H2O, Sigma-Aldrich) in the presence of 
xylenol orange (Sigma-Aldrich). With each addition of gadolinium, an aliquot was mixed 
with xylenol orange until the color changed from yellow to pick, indicating saturation of 





2.2 Liposome Fabrication 
 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine (DC8,9PC, Avanti 
Polar Lipids) was dissolved in chloroform at a concentration of 20 mg/mL. During all 
handling of lipids, samples were protected from light to avoid unintended cross-linking. 
The lipid solution was transferred to a 50 mL capacity round bottom flask and the 
chloroform was removed by rotary evaporation, leaving a thin lipid film. The film was 
then hydrated with deionized water at 50 °C to a lipid concentration of 1 mg/mL. 
Liposomes were then cooled in an ice bath, sonicated for 15 minutes, and stored at 4 °C. 
 
2.3 Liposome Coating and Cross-Linking 
 To coat pre-formed vesicles, liposomes were incubated with a DTPA-chitosan-g-
C18 solution at a molar ratio of 5:1 glucosamine unit to outer leaflet lipid. To ensure 
equilibration, the mixture stirred overnight. Excess chitosan was then removed by 
centrifugation for 10 minutes at 4,000 rpm to pellet the liposomes. Non-adsorbed 
chitosan remaining in the supernatant was removed and the coated liposomes were re-
suspended in deionized water. 
 Cross-linking of lipids was carried out either before or after binding with 
modified chitosan. In either case, lipids were cross-linked for 10 minutes at 4 °C with 
light at a wavelength of 254 nm (Jelight Co.). After cross-linking, the liposome 





2.4 Binding and Stability of Fluorescently Labeled DTPA-Chitosan-g-C18 
 To quantify the amount of chitosan associated with liposomes, DTPA-chitosan-g-
C18 was first fluorescently labeled. Briefly, the modified chitosan was dissolved in 
deionized water and incubated overnight with a solution of the amine reactive 
fluorophore, rhodamine B isothiocyanate (Sigma-Aldrich). Following conjugation, excess 
rhodamine was removed by dialysis and the labeled chitosan was lyophilized. For 
quantitation, fluorescent DTPA-chitosan-g-C18 was dissolved in deionized water and 
incubated with liposomes as described. Then, following purification by centrifugation, 
the fluorescent intensities of the supernatant and re-suspended liposomes were analyzed 
by microplate reader (Tecan Infinite 200 PRO, Tecan AG, Switzerland) with excitation at 
535 nm and emission at 595 nm. 
 To examine the stability of the association under stressed conditions, coated 
liposomes were re-suspended in serum-supplemented media rather than deionized water 
after removal of excess fluorescent chitosan. Media consisted of 10% type AB human 
serum off the clot (PAA Laboratories Inc.) in phosphate buffered saline (PBS). Samples 
re-suspended in the serum media were then incubated at 37 °C. At each time point, 30 
and 60 minutes, a sample was removed from incubation and centrifuged for 10 minutes at 
4,000 rpm. It was then re-suspended and analyzed for fluorescent intensity to determine 
how much of the initial amount had been desorbed into the supernatant. Background 
interference from serum, though minimal, was subtracted from the experimental samples 
for accurate quantitation. 
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2.5 Thermodynamics of Binding Between DTPA-Chitosan-g-C18 and Cross-
Linkable Liposomes 
 Isothermal titration calorimetry (ITC) was carried out with a VP-ITC calorimeter 
(MicroCal, Northampton, MA). Experiments were performed at 25 °C with DTPA-
chitosan-g-C18 at a concentration of 5 mM glucosamine unit titrated into the 1.45 mL 
well of liposome suspension. 28 injections were made over 17.1 s each with a delay of 
300 s between injections. The injection volume was 10 µL and the syringe stirred at 310 
rpm. Analysis was done with Origin 5.0 software from MicroCal using a single-site 
binding model. 
 
2.6 Magnetic Resonance Imaging of Gadolinium-Loaded Liposomes 
 To prepare gadolinium-loaded liposomes, the lipid vesicles were incubated with 
DTPA-chitosan-g-C18 as described. Then, after removal of free chitosan by 
centrifugation, gadolinium was added incrementally until all DTPA binding sites on the 
liposome surface were occupied, as indicated by xylenol orange assay. Samples were 
then incubated at 37 °C with 10% serum in PBS. After one hour, samples were 
centrifuged again to remove gadolinium-bound DTPA-chitosan-g-C18 that was desorbed 
during incubation. To prepare the samples for MRI, a concentration series was made 
using borosilicate cell culture tubes. The tubes were then placed in an agar gel to 
immobilize the samples and reduce imaging artifacts. 
 Imaging was completed with a 3 T Siemens Magnetom Trio clinical scanner 
(Siemens AG, Erlangen, Germany). Image acquisition was performed with an inversion 
recovery turbo spin echo (IR-TSE) sequence with a slice thickness of 3.0 mm, repetition 
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time (TR) of 2,500 ms, echo time (TE) of 18.0 ms, and inversion time (TI) ranging from 
100 to 1,700 ms. For each TI, signal intensity was measured using ImageJ software and 
used to determine the spin-lattice relaxation time (T1) of each phantom by non-linear least 
squares curve fitting. 
 To determine molar relaxivity, the concentration of gadolinium per sample was 
ascertained by inductively couple plasma optical emission spectroscopy (ICP-OES, 
Perkin Elmer Optima 2000 DV, Norwalk, CT). Prior to analysis, samples were digested 
in nitric acid to induce sample degradation. Relaxation rate was plotted against 




RESULTS AND DISCUSSION 
 
3.1 Formulation of Liposomes Coated with DTPA-Chitosan-g-C18 
Liposomes were formed by film hydration of 1,2-bis(10,12-tricosadiynoyl)-sn-
glycero-3-phosphocholine, termed DC8,9PC, lipids. As shown in Figure 1a, DC8,9PC 
lipids are cross-linked upon UV irradiation at 254 nm. This is due to the diyne 
functionality, in which alkynes on adjacent hydrophobic chains are able to bond and 
polymerize the liposome. This strategy has been used to create local regions of reduced 
mobility within mixed lipid bilayers for photo-triggered drug release.14 However, in the 
case of liposomes formed solely with DC8,9PC, cross-linking induces a continuous shell 
within the bilayer. Successful cross-linking was indicated by a color change of the 
liposome suspension from white to orange (Figure 1b). 
In previous work, we developed a chitosan modified with the gadolinium chelate, 
DTPA, and an 18-carbon hydrophobic anchor (unpublished data). Chitosan, a 
polysaccharide consisting of glucosamine repeat units, has previously been shown to 
adsorb to liposome surfaces primarily through electrostatic associations, and to a lesser 
extent, hydrophobic interactions, hydrogen bonding, and van der Waals forces.15 In our 
case, the DTPA-modified glucosamine unit served not only to chelate gadolinium for 
MRI contrast enhancement, but also provided additional electrostatic interaction and 
afforded water solubility at neutral or physiological pH to the chitosan backbone. The 18-
carbon anchor takes advantage of the fluid-like nature of the liposome structure by 
inserting into the hydrophobic region of the bilayer. The degree of substitution of DTPA 
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(DSDTPA) was found to be 15.4%, while that of the alkyl chain (DSC18) was 4.2%. In the 
present study, to create the liposome-chitosan association, the functionalized chitosan 
was dissolved in deionized water and mixed with pre-formed lipid vesicles. In the case of 
DC8,9PC-based liposomes, chitosan was incubated at a 5:1 glucosamine unit-to-outer 
leaflet lipid ratio to induce adsorption and saturate the liposome surface.  
Here, we examined three liposome-chitosan systems (Figure 2). In the first case, 
the functionalized chitosan was adsorbed to DC8,9PC liposomes without inducing the 
cross-linking reaction. The second case consisted of adsorbing chitosan to pre-cross-
linked liposomes. Thirdly, we investigated the system in which chitosan was first 
adsorbed to the liposome, followed by cross-linking of lipids afterwards. 
 
3.2 Evaluation of DTPA-Chitosan-g-C18 Binding to Cross-Linkable Liposomes 
 To quantify the binding stoichiometry between modified chitosan and liposome in 
each of the three cases, DTPA-chitosan-g-C18 was fluorescently labeled with rhodamine-
B isothiocyanate, which readily reacted with the primary amine groups on unmodified 
glucosamine units. In this way, it was possible to analyze the fluorescent intensity of re-
suspended liposomes, as well as supernatant, after centrifugation to remove free chitosan 
and pellet the vesicles. Fluorescent intensity was used for quantitation by relating it to 
calibration against known chitosan concentration. Binding stoichiometry was defined in 
terms of the ratio between glucosamine repeat unit to exposed lipid on the outer leaflet, 
which is assumed to be half of the total lipids. Results for the three cases tested after 
incubation with a five-fold molar excess of glucosamine units are shown in Figure 3. 
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 In the two cases where the modified chitosan was initially adsorbed to uncross-
linked liposomes, the binding stoichiometry was nearly 2.5:1 glucosamine unit-to-
exposed lipid. The polymerization of the lipids did not induce desorption, nor provide a 
mechanism of additional adsorption of chitosan, since the binding stoichiometry was 
equivalent between liposomes cross-linked after adsorption to liposomes that were not 
cross-linked at all. Interestingly, however, in the case where DTPA-chitosan-g-C18 was 
incubated with pre-cross-linked liposomes, the binding was 1:1. In this way, 
polymerization of the bilayer interfered with the ability of the liposome to bind with 
chitosan. This may be due to steric hindrance as lipids adopt a rigid conformation that 
may be unfavorable for interaction with the chitosan. Similarly, by reducing the fluidity 
of the bilayer, lipids cannot rotate or translocate to accommodate the binding. In 
particular, the hydrophobic anchor may not be able to insert into the rigid bilayer. 
 To further examine the binding between liposome and chitosan, isothermal 
titration calorimetry (ITC) was performed. Liposomes were formed by film hydration as 
described, and then titrated with DTPA-chitosan-g-C18. The case of uncross-linked 
liposomes was compared to those that were cross-linked to determine whether cross-
linked lipids would be detrimental to the thermodynamic association between liposome 
and chitosan. The resultant thermograms are shown in Figure 4. 
 From the heat flow data, it is apparent that in both cases, the association was 
endothermic as indicated by the positive change in heat with each injection of DTPA-
chitosan-g-C18. As shown previously, the interaction between chitosan and similar 
zwitterionic lipids can present an increase in enthalpy.16 To extract binding ratios, 
binding constant, and enthalpy of association from the raw data in Figure 4, a single-site 
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binding model was applied.17 This model can be derived by first defining the binding 
constant as follows:  
K = X
(1! X)Cfree
           (1) 
where X is the fraction of lipids bound by DTPA-chitosan-g-C18, and Cfree is the 
concentration of glucosamine unit that remains free in solution rather than bound to a 
liposome. This can be related to the total glucosamine concentration, Ct as shown in 
Equation 2: 
Ct =Cfree + NXLt            (2) 
in which the quantity NXLt represents the concentration of bound glucosamine with N 
representing the binding ratio and Lt as the total lipid concentration. Combining 
Equations 1 and 2 yields the following quadratic equation: 













= 0           (3) 
With the parameters Ct and Lt known by experimental design, it is necessary to 
relate X to the measured heat flow data to determine N and K, as well as enthalpy, !H. 
This is done by relating the heat content of solution, Q, in its volume, V0, and substituting 
into Equation 3: 































        (5) 
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By fitting heat flow data for each successive injection, it is then possible to extract the fit 
parameters of N, K, and !H. For the two systems examined, these data are summarized in 
Table 1. 
 As in the study described in the previous section, the binding ratio (N) between 
the glucosamine units and total lipids was more than two-fold greater in the case of 
uncross-linked liposomes compared to those that were pre-cross-linked. Additionally, the 
binding constant, K, was also greater in the case of uncross-linked liposomes. This can be 
translated to the change in Gibb’s free energy as follows: 
!G = "RT ln(K )            (6) 
where T is temperature and R is the universal gas constant. Accordingly, !G was more 
negative, hence more thermodynamically favorable, in the case of lipids that were not 
cross-linked. It has been demonstrated previously that insertion of a hydrophobic domain 
into a lipid bilayer contributes to the negative change in !G.18, 19 Therefore the 
differences in !G are consistent with the hypothesis that in the case of pre-cross-linked 
liposomes, the 18-carbon anchor attached to chitosan has a more limited capability to 
insert into the liposome and provide anchoring. This is depicted schematically in Figure 2 
as the case where the alkyl chain either does not insert, thus remaining in the aqueous 
exterior, or inserts only partially into the bilayer. In either case, the binding would not be 
as favorable, and the association weaker. 
 This is also in agreement with the trend in change in entropy, !S, which is 
determined from the other thermodynamic parameters as follows: 
!S = !H "!G
T
           (7) 
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The entropy-driven process was previously shown to be enhanced by the entropic 
contribution of the alkyl chain insertion (unpublished data). This is due to the desolvation 
of water molecules surrounding the 18-carbon chain, and the gain in configurational 
entropy they acquire in doing so, consistent with the hydrophobic effect.20, 21 Therefore, 
the smaller change in entropy in the case of the cross-linked liposome may again be due 
to incomplete insertion of the alkyl anchor as a result of the cross-linking. 
 
3.3 Stability of Liposome Coatings in Serum 
 As serum can be detrimental to the stability of assembled structures in vivo, it is 
important to assess stability in its presence. Here, we monitored the stability of the 
chitosan-liposome association in 10% human serum in PBS at 37 °C. Rhodamine-labeled 
DTPA-chitosan-g-C18 was incubated overnight with DC8,9PC liposomes in the three cases 
described: no cross-linking, pre-adsorption cross-linking, and post-adsorption cross-
linking. Excess chitosan was then removed by centrifugation, and the coated liposomes 
were re-suspended in the serum solution. At 30 and 60 minutes, samples were pelleted 
and re-suspended again to determine how much of the fluorescent chitosan remained with 
the liposomes versus desorption and collection into supernatant. The results are shown in 
Figure 5. 
 The percent of coated liposomes remaining was determined from the amount of 
coated liposomes at the time points tested compared to liposomes prior to serum addition. 
In the cases of uncross-linked liposomes and liposomes cross-linked prior to addition of 
the modified chitosan, more than half of the chitosan was desorbed over the course of an 
hour in serum. There was no statistical difference in the percent desorbed between these 
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two cases. However, when DTPA-chitosan-g-C18 was adsorbed to the liposome prior to 
cross-linking, the enhancement was dramatic. Approximately 75% of the initial amount 
adsorbed remained after 30 minutes, and no further desorption was observed for the 
remainder of the hour in serum. The mechanism of stabilization is likely two-fold: 
stabilization of the liposome itself, and stabilization of its association with the modified 
chitosan. Cross-linking of lipids has been shown to improve liposome stability under the 
stress of surfactant addition.22 In the present study, this would enhance the number of 
liposomes in the pellet, and therefore the amount of chitosan quantified in the re-
suspension versus supernatant. However, since there was no difference between 
liposomes cross-linked before chitosan addition and those remaining uncross-linked, this 
cannot be the full picture. The improved stability of the post-adsorption cross-linked 
liposomes must also be explained in terms of the adsorption stabilization. Unlike the case 
of pre-adsorption cross-linked liposomes, the post-adsorption sample allows for complete 
insertion of the hydrophobic anchor, thus providing better anchoring in serum. 
Additionally, compared to liposomes that were not cross-linked, the reduced fluidity of 
the lipid bilayer reduces the likelihood of the anchor becoming detached from the outer 
leaflet. In this way, we hypothesize that the stability enhancement afforded by cross-
linking after adsorption is a result of the ability of the18-carbon chain to insert into the 
bilayer, and remain inserted in the presence of elevated temperature and serum. 
 In consideration of differences in initial binding stoichiometry in conjunction with 
the percent desorbed, the molar amount of chitosan adsorbed per liposome after an hour 
in serum further demonstrates the utility of the post-adsorption cross-linked liposome 
(Figure 5b). Unlike Figure 3, glucosamine binding is stated per total lipid rather than 
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exposed lipid since some liposomes were likely ruptured during the incubation period. 
Uncross-linked liposomes had the same amount of DTPA-chitosan-g-C18 adsorbed as 
liposomes cross-linked post-adsorption initially. However, due to differences in stability, 
the amount remaining after an hour was almost half. Moreover, in comparing liposomes 
cross-linked before or after adsorption, the post-adsorption case represent a four-fold 
increase in the amount of chitosan adsorbed after an hour due to differences in initial 
stoichiometry as well as stability. 
 
3.4 Magnetic Resonance Contrast Enhancement by Coated Liposomes 
 As pre- and post-adsorption cross-linked liposomes represented extremes in 
stabilization of the chitosan anchor, it was important to evaluate the functionality of the 
two systems in providing diagnostic capability. Gadolinium, which is chelated by DTPA, 
is used clinically to provide positive contrast in magnetic resonance images by 
coordinating with surrounding water molecules and shorting T1 relaxation times. 
Gadolinium is always administered in the form of a chelate to mitigate concerns of 
toxicity. To load gadolinium on the liposome surface, cross-linked liposomes coated with 
DTPA-chitosan-g-C18 were titrated with gadolinium until all DTPA binding sites were 
saturated. This was verified by colorimetric titration with xylenol orange. This indicator 
solution is yellow in color, until coordinated with gadolinium, at which point the solution 
turns pink. DTPA has a much high binding affinity for gadolinium than xylenol orange, 
thus, xylenol orange can be used as an indicator to determine the presence of free, rather 
than chelated, gadolinium.23 In the case of the coated liposomes, gadolinium was added 
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incrementally to an aliquot of liposome suspension in the presence of xylenol orange 
until the color change was observed. 
 After loading of the coated liposomes with gadolinium, samples were incubated 
for one hour in PBS supplemented with 10% human serum at 37 °C as in the adsorption 
stability study. Desorbed chitosan, loaded with gadolinium, was removed by 
centrifugation, and the remaining coated liposomes were used to create a concentration 
series of MR phantoms. Phantoms were placed in agar gels for imaging, and coronal 
cross sections were visualized with a 3 T clinical scanner using an IR-TSE sequence 
(Figure 6a). 
As shown in Figure 6b, for any given lipid concentration, the signal intensity was 
much greater in the case of liposomes cross-linked after DTPA-chitosan-g-C18 
adsorption. This is likely due to the higher concentration of gadolinium per liposome 
sample as a result of the differences in binding stoichiometry and desorption as discussed 
in Figure 5b. Gadolinium concentration was analyzed by ICP-OES to determine the 
differences in content. The amount of gadolinium present per lipid was nearly four-fold 
greater in the case of post-adsorption cross-linked liposomes, consistent with the 
observation that four times as much modified chitosan remained with post-adsorption 
cross-linked liposomes. To verify that differences in signal were due solely to differences 
in gadolinium concentration, it was necessary to calculate the molar relaxivity for the two 
cases. 
For an IR-TSE sequence, the MR signal for a given inversion time, TI, is 
described by Equation 8:24 
S(TI ) = S0 1! 1! k( )e!TI /T1"# $%            (8) 
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where S0 represents signal at thermal equilibrium, k depends on flip angle and 
magnetization of the system, and T1 is the spin-lattice relaxation time. As such, regions 
with shorter T1 have brighter signal intensities. For example, fatty tissue has short T1 and 
can often be distinguished from surrounding tissue in an MR image. The shortening of T1 
by gadolinium enhances signal in this way. The quantity 1/ T1 is referred to as the 
relaxation rate, R1 and is defined as follows: 
R1 = R1,water + r1[Gd]                   (9) 
where R1,water is the relaxation rate of contrast agent-free water, [Gd] is the concentration 
of gadolinium, and r1 is the molar relaxivity of the contrast agent. In this way, signal can 
be enhanced by higher gadolinium concentration or higher relaxivity. 
 For each phantom, T1 was determined by three parameter nonlinear least squares 
fitting to Equation 8 as TI was varied. An example plot is shown in Figure 6c. Note from 
the shape of the curve that when signal would theoretically become negative, it is 
transposed across the x-axis to give positive signal in the resultant MR image. For the two 
cases, R1 was plotted versus gadolinium concentration of each phantom to yield the 
relaxivity by linear regression of Equation 9. The relaxivity of pre-adsorption cross-
linked liposomes was 6.52 ± 0.47 mM-1s-1, and that of post-adsorption liposomes was 
6.50 ± 0.16 mM-1s-1. Since these values were equivalent, differences in signal intensity 
arose solely from differences in gadolinium concentration. The high loading of 
gadolinium per liposome makes the post-adsorption cross-linked liposomes superior for 
biomedical imaging, and in particular, targeted imaging. With the four-fold increase in 
loading, only one quarter of the amount of liposomes would be required to accumulate at 
a target site, compared to pre-adsorption cross-linked liposomes, to provide a given T1 
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relaxation rate. Alternatively, the signal at the target would be greatly enhanced for any 
specific quantity of accumulated liposome. 
 Taken together, the results of these studies demonstrate the superior ability of 
liposomes cross-linked post chitosan adsorption to stably retain the chitosan anchor. In 
this way, these liposomes provided high MR contrast even after incubation in serum-
supplemented media. To improve the chitosan anchor, the degree of substitution of 
DTPA could be increased to further augment the loading of gadolinium per liposome. 
Additionally, the number of alkyl chains per molecule could be increased to provide 
further binding stability. Such strategies for stabilization of micro- or nanoparticles will 
be critical for the development of future diagnostics or treatments that must remain stable 
until reaching their target site after injection. In this way, the system described in this 




3.5 Figures and Tables 
 
Figure 1. Liposomes with a continuous shell via cross-linking of bilayer. (a) Schematic 
depicting the photo-initiated polymerization of the lipid bilayer. (b) Liposome 
suspensions appear white in color prior to cross-linking (i), but turn orange after exposure 















































Figure 2. Schematic of association between DTPA-chitosan-g-C18 and DC8,9PC 
liposomes in three scenarios: (1) liposomes without a cross-linked bilayer, (2) liposomes 

































Figure 3. The number of glucosamine units bound per exposed lipid after adsorption to 
pre-formed liposomes in three different formulation conditions. Error bars represent 





























Figure 4. ITC thermograms comparing the heats of association between DTPA-chitosan-
g-C18 and liposomes with uncross-linked bilayer or cross-linked bilayer. Heat flow data is 







Figure 5. Stability of DTPA-chitosan-g-C18 in serum-supplemented media for the case of 
liposomes without cross-linked bilayer ("), pre-adsorption cross-linking of lipid bilayer 
(#), and post-adsorption cross-linking of bilayer ($). (a) The percent remaining of the 
initial amount adsorbed. (b) The total amount of DTPA-chitosan-g-C18 remaining, per 






 Figure 6. MR analysis of coated liposome phantoms. (a) Schematic of phantom solution 
with coronal cross section. (b) Pseudo-colored MR image of liposomes cross-linked 
before or after DTPA-chitosan-g-C18 adsorption (TI = 1250 ms). The concentration series 
is shown per lipid dose, and coloration represents signal intensity values. (c) Example 
intensity plot for determination of T1 by varying TI. The plot shown is for post-adsorption 
cross-linked liposomes at a 0.75 mg/mL lipid concentration. (d) Gadolinium-based molar 
relaxivity plots for the two liposome samples. Error bars represent standard deviation of 




Table 1. Binding parameters for the association between DC8,9PC liposomes and DTPA-
chitosan-g-C18. Molar amounts are listed per mole of glucosamine unit. 
  
Liposome N K !H !G !S 
  
104 M-1 kcal/mol kcal/mol cal/mol!K 
Uncross-Linked 1.10 ± 0.06 2.04 ± 0.33 3.14 ± 0.02 -5.87 30.2 
















 This study has demonstrated a strategy to stabilize liposomes coated with a 
functional anchor post-fabrication. The system consisted of liposomes made from cross-
linkable DC8,9PC lipids, and chitosan modified with a hydrophobic anchor and the 
gadolinium chelate, DTPA. Three liposome systems were compared: liposomes that were 
never cross-linked, those that were cross-linked prior to addition of the functional 
chitosan, and those cross-linked after chitosan adsorption. While cross-linked liposomes 
are known to stabilize the system, the order of cross-linking versus adsorption was 
critical in formulation design. Liposomes that were cross-linked after chitosan was 
adsorbed were able to associate with a significantly greater number of glucosamine units 
of chitosan, and the chitosan that was adsorbed was far more stable in the presence of 
serum. This is likely due in part to the enhanced ability of the hydrophobic anchor to 
insert into the lipid bilayer and provide thermodynamically favorable binding, as 
supported by ITC, and remain inserted due to reduced mobility of lipids upon cross-
linking. As a result, the MR signal enhancement per dose of liposome was dramatically 
increased compared to liposomes adsorbed with chitosan after cross-linking. Overall, this 
strategy of stabilizing a functional anchor to liposome surfaces extends beyond the 
system described. The same concept can be readily applied to anchors that impart 
enhanced targeting, multimodal imaging, or stealth capabilities, all of which would 
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benefit from surface localization and stability enhancement in the harsh environment of 
in vivo circulation. 
 
4.2 Future Work 
 For future studies, it will be important to verify stability of the liposome itself in 
the presence of serum. Liposomes under stressed conditions release their encapsulated 
contents either by degradation and disassembly of the lipid bilayer, or by increased 
permeability of the vesicle that allows for release through a leaky bilayer. To test the 
former scenario, stability of liposomes is often measured by dynamic light scattering to 
record particle count or diameter of the sample over time.22 For the latter case, stability 
can be monitored by leakage of a reporter molecule. For example, bovine serum albumin 
is often used as a model protein25 in which slower release rates indicate greater liposome 
stability. Alternatively, fluorescent molecules are frequently exploited for their ability to 
quench within the liposome, and fluoresce when released. Calcein, a hydrophilic marker, 
can be encapsulated within the aqueous interior of the liposome,26 while 
octadecylrhodamine B partitions in the hydrophobic bilayer.27 In either case, liposome 
stability is monitored by measuring the increase in fluorescent intensity as the marker is 
released upon liposomal leaking or degradation. 
 We hypothesize that cross-linking the DC8,9PC liposomes will enhance their 
stability. The covalent polymerization creates a shell to limit degradation of the vesicle, 
and it has been shown previously by others that cross-linking of lipids enhances stability 
in the presence of the nonionic surfactant, Triton X-100.22 In our case, we propose that 
the liposome system in which DTPA-chitosan-g-C18 is adsorbed prior to cross-linking 
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will be able to take advantage not only of the enhanced stability of the chitosan anchor, 
but will also have superior retention of encapsulated material compared to uncross-linked 
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